Analyst Ranking
Top 4%
#157 out of 5069 analysts
Average Return
+17.86%
Win Rate
43%111 out of 259
Risk vs Reward
Poor
Good

Keay Nakae's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Ocugen IncOCGN
+5,554.71%$0.22$12.61
2020-06-03 -
2021-02-09
Strong Buy
Avidity Biosciences IncRNA
+347.81%$9.35$41.87
2023-08-09 -
2024-08-08
Strong Buy
Dyne Therapeutics IncDYN
+253.51%$11.55$40.83
2023-08-04 -
2024-08-02
Strong Buy
Korro Bio IncKRRO
+213.15%$13.46$42.15
2025-04-16 -
2025-10-17
Strong Buy
Sonnet Biotherapeutics Holdings IncSONN
+202.50%$1.20$3.63
2025-04-07 -
2025-10-17
Strong Buy

Keay Nakae Analyst Color

Get additional color on Keay Nakae's coverage of popular stocks

Keay Nakae's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Monopar TherapeuticsMNPR
4Strong Buy$85.00+6.08%Maintains
24 days ago
Sab Biotherapeutics IncSABS
16Strong Buy$12.00+378.09%Maintains
a month ago
Coya Therapeutics IncCOYA
21Strong Buy$14.00+120.13%Maintains
a month ago
Avidity Biosciences IncRNA
19Strong Buy$75.00+56.61%Maintains
a month ago
Orchestra Biomed Holdings IncOBIO
12Strong Buy$20.00+502.41%Maintains
2 months ago
Korro Bio IncKRRO
3Strong Buy$25.00-40.69%Maintains
2 months ago
Arrowhead Pharmaceuticals IncARWR
16Strong Buy$60.00+63.00%Maintains
2 months ago
Arbutus Biopharma CorpABUS
12Strong Buy$5.00+13.38%Maintains
2 months ago
Proqr Therapeutics NvPRQR
12Strong Buy$4.00+43.88%Maintains
2 months ago
Silence Therapeutics PLCSLN
13Strong Buy$35.00+438.46%Maintains
2 months ago
Alnylam Pharmaceuticals IncALNY
12Strong Buy$400.00-16.96%Maintains
3 months ago
Dyne Therapeutics IncDYN
13Strong Buy$38.00+131.99%Maintains
3 months ago
Ibio IncIBIO
5Strong Buy$5.00+488.24%Maintains
4 months ago
Seres Therapeutics IncMCRB
10Hold$6.00-68.27%Downgrades
5 months ago
Sonnet Biotherapeutics Holdings IncSONN
13Strong Buy$20.00+450.96%Maintains
6 months ago
Gain Therapeutics IncGANX
6Strong Buy$6.00+220.86%Maintains
7 months ago
Allurion Technologies IncALUR
5Hold$2.50+25.94%Maintains
7 months ago
Femasys IncFEMY
10Strong Buy$8.00+1,037.98%Maintains
a year ago
Omega Therapeutics IncOMGAQ
6Strong Buy$6.00N/AMaintains
a year ago
Notable Labs LtdNTBLQ
2Strong Buy$5.00N/AMaintains
a year ago
Synlogic IncSYBX
4Strong Buy$90.00N/AReiterates
2 years ago
Better Therapeutics IncBTTX
6Strong Buy$9.00N/AReiterates
2 years ago
Mesoblast LtdMESO
7Strong Sell$6.00N/AMaintains
2 years ago
Pear Therapeutics IncPEARQ
5Hold$8.00N/ADowngrades
3 years ago
Evelo Biosciences IncEVLO
4Hold$50.00N/ADowngrades
3 years ago
Biomx IncPHGE
4Strong Buy$20.00N/AMaintains
3 years ago
Emergent Biosolutions IncEBS
8Strong Buy$55.00N/AMaintains
3 years ago
Axcella Health IncAXLA
4Strong Buy$125.00N/AMaintains
3 years ago
Neubase Therapeutics IncNBSE
5HoldN/AN/ADowngrades
3 years ago
Exicure IncXCUR
5Hold$10.00N/AMaintains
3 years ago
4d Pharma PLCLBPS
1HoldN/AN/ADowngrades
3 years ago
Kaleido Biosciences IncKLDO
3Hold$1.70N/ADowngrades
4 years ago
Dicerna Pharmaceuticals IncDRNA
3Hold$38.25N/ADowngrades
4 years ago
Forte Biosciences IncFBRX
2Hold$87.50N/AUpgrades
4 years ago
Ocugen IncOCGN
2Hold$13.00N/ADowngrades
5 years ago
Insight Molecular Diagnostics IncIMDX
2Hold$40.00N/ADowngrades
5 years ago
Lisata Therapeutics IncLSTA
1Strong Buy$7.00N/AMaintains
8 years ago
Carecloud IncCCLD
1Strong Buy$2.75N/AMaintains
8 years ago
Biocept IncBIOCQ
1Strong Buy$22,500.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.